SPSIPB Versus SAPB for Postoperative Analgesia After Minimally Invasive Repair of Pectus Excavatum
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-25
SponsorMarmara University
About this trial
This prospective observational cohort study will compare postoperative analgesic outcomes in patients undergoing minimally invasive repair of pectus excavatum. Participants will be grouped according to the regional analgesia technique applied as part of routine clinical care: serratus posterior superior intercostal plane block or serratus anterior plane block. The primary outcome will be total opioid consumption during the first 24 hours after surgery. Secondary outcomes will include postoperative pain scores, rescue analgesic requirement, opioid-related adverse effects, patient satisfaction, mobilization time, and length of hospital stay.
Eligibility criteria
Qualifiers
Patients aged 15 to 25 years
Diagnosis of pectus excavatum
Scheduled to undergo minimally invasive repair of pectus excavatum under general anesthesia
Receipt of either bilateral serratus posterior superior intercostal plane block or bilateral serratus anterior plane block as part of routine perioperative analgesic care
Disqualifiers
Refusal to participate in the study
Contraindication to regional anesthesia
Known allergy to local anesthetics or study analgesic medications
Chronic opioid use
Trial design
Treatments tested in this trial
- Postoperative Analgesia Protocol
- Bispectral Index Monitoring
- Serratus Posterior Superior Intercostal Plane Block
- Serratus Anterior Plane Block
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov